BOSTON SCIENTIFIC CORP - 8-K Filing
Boston Scientific invested $1.5 billion (plus an additional $3.0 billion option) to acquire a 34% stake in MiRus LLC, a developer of the SIEGEL TAVR system for treating cardiovascular diseases. The deal includes an exclusive option to fully acquire the TAVR business after achieving clinical and regulatory milestones. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $BSX